Unemo, M., Golparian, D., Oxelbark, J., Kong, F. Y. S., Brown, D., Louie, A., . . . Jacobsson, S. (2024). Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea. Journal of antimicrobial chemotherapy, 79(5), 1006. https://doi.org/10.1093/jac/dkae063
Chicago-Zitierstil (17. Ausg.)Unemo, Magnus, Daniel Golparian, Joakim Oxelbark, Fabian Y S. Kong, David Brown, Arnold Louie, George Drusano, und Susanne Jacobsson. "Pharmacodynamic Evaluation of Ceftriaxone Single-dose Therapy (0.125-1 g) to Eradicate Ceftriaxone-susceptible and Ceftriaxone-resistant Neisseria Gonorrhoeae Strains in a Hollow Fibre Infection Model for Gonorrhoea." Journal of Antimicrobial Chemotherapy 79, no. 5 (2024): 1006. https://doi.org/10.1093/jac/dkae063.
MLA-Zitierstil (9. Ausg.)Unemo, Magnus, et al. "Pharmacodynamic Evaluation of Ceftriaxone Single-dose Therapy (0.125-1 g) to Eradicate Ceftriaxone-susceptible and Ceftriaxone-resistant Neisseria Gonorrhoeae Strains in a Hollow Fibre Infection Model for Gonorrhoea." Journal of Antimicrobial Chemotherapy, vol. 79, no. 5, 2024, p. 1006, https://doi.org/10.1093/jac/dkae063.